SEELOS THERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Seelos Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Seelos Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was 92.8 %.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2023 was -321 %, a 104% decline from 2022.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2022 was -158 %, a 76.7% decline from 2021.
  • Seelos Therapeutics, Inc. annual Return On Assets for 2021 was -89.2 %, a 42.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 92.8 +422 Apr 1, 2024 Jun 30, 2024
Q1 2024 -400 -191 -91.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -321 -164 -104% Oct 1, 2023 Dec 31, 2023
Q3 2023 -317 -184 -139% Jul 1, 2023 Sep 30, 2023
Q2 2023 -329 -227 -222% Apr 1, 2023 Jun 30, 2023
Q1 2023 -209 -134 -179% Jan 1, 2023 Mar 31, 2023
Q4 2022 -158 -68.4 -76.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -133 -54.2 -68.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -102 -5.08 -5.25% Apr 1, 2022 Jun 30, 2022
Q1 2022 -74.9 +99.7 +57.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -89.2 +65.8 +42.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.6 +139 +63.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -96.9 +85.5 +46.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -175 -15.6 -9.78% Jan 1, 2021 Mar 31, 2021
Q4 2020 -155 +256 +62.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -217 +211 +49.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -182 +377 +67.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -159 +446 +73.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -411 -337 -461% Oct 1, 2019 Dec 31, 2019
Q3 2019 -429 -355 -482% Jul 1, 2019 Sep 30, 2019
Q2 2019 -559 -456 -441% Apr 1, 2019 Jun 30, 2019
Q1 2019 -605 -495 -446% Jan 1, 2019 Mar 31, 2019
Q4 2018 -73.2 -77.5 -1792% Oct 1, 2018 Dec 31, 2018
Q3 2018 -73.7 -109 -307% Jul 1, 2018 Sep 30, 2018
Q2 2018 -103 -177 -241% Apr 1, 2018 Jun 30, 2018
Q1 2018 -111 -162 -317% Jan 1, 2018 Mar 31, 2018
Q4 2017 4.32 +104 Oct 1, 2017 Dec 31, 2017
Q3 2017 35.7 +151 Jul 1, 2017 Sep 30, 2017
Q2 2017 73.5 +229 Apr 1, 2017 Jun 30, 2017
Q1 2017 51.1 +205 Jan 1, 2017 Mar 31, 2017
Q4 2016 -100 +57.1 +36.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -115 +130 +52.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -156 +39.9 +20.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -154 -20.4 -15.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -157 -48.1 -44.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -245 -219 -827% Jul 1, 2015 Sep 30, 2015
Q2 2015 -195 -170 -677% Apr 1, 2015 Jun 30, 2015
Q1 2015 -134 -86.6 -183% Jan 1, 2015 Mar 31, 2015
Q4 2014 -109 -33.1 -43.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -26.4 +131 +83.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -25.2 +103 +80.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -47.3 +82.1 +63.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -76 +25.1 +24.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 -157 -100 -176% Jul 1, 2013 Sep 30, 2013
Q2 2013 -128 -56.2 -77.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -129 -27.9 -27.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -101 Oct 1, 2012 Dec 31, 2012
Q3 2012 -56.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -72.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -101 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.